Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AIM CVE:MTO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIMAIM ImmunoTech$2.60$4.59$2.33▼$36.00$7.04M0.9864,820 shs30,782 shsMTOMetanor Resources Inc. (MTO.V)C$0.58C$0.58C$0.46▼C$0.82C$59.13MN/A80,421 shs232,400 shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIMAIM ImmunoTech0.00%+4.84%+1.17%-71.55%-91.61%MTOMetanor Resources Inc. (MTO.V)0.00%0.00%0.00%0.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIMAIM ImmunoTech$2.60$4.59$2.33▼$36.00$7.04M0.9864,820 shs30,782 shsMTOMetanor Resources Inc. (MTO.V)C$0.58C$0.58C$0.46▼C$0.82C$59.13MN/A80,421 shs232,400 shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIMAIM ImmunoTech0.00%+4.84%+1.17%-71.55%-91.61%MTOMetanor Resources Inc. (MTO.V)0.00%0.00%0.00%0.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAIMAIM ImmunoTech 3.50Strong Buy$275.0010,476.92% UpsideMTOMetanor Resources Inc. (MTO.V) 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest RCDO, XIP, MTO, AIM, and ASY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/5/2025AIMAIM ImmunoTechMaxim GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy(Data available from 9/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAIMAIM ImmunoTech$121K58.21N/AN/A$0.20 per share13.00MTOMetanor Resources Inc. (MTO.V)C$26.37M2.24C$0.01 per share64.44C$0.20 per share2.97Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAIMAIM ImmunoTech-$28.96M-$24.68N/AN/AN/A-12,594.21%-421.73%-147.54%N/AMTOMetanor Resources Inc. (MTO.V)N/A-C$0.27N/A∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAIMAIM ImmunoTechN/AN/AN/AN/AN/AMTOMetanor Resources Inc. (MTO.V)N/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAIMAIM ImmunoTech0.050.750.75MTOMetanor Resources Inc. (MTO.V)12.700.580.27Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAIMAIM ImmunoTech12.02%MTOMetanor Resources Inc. (MTO.V)N/AInsider OwnershipCompanyInsider OwnershipAIMAIM ImmunoTech0.02%MTOMetanor Resources Inc. (MTO.V)N/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAIMAIM ImmunoTech202.71 million68.74 millionNot OptionableMTOMetanor Resources Inc. (MTO.V)18,000101.95 millionN/ANot OptionableRCDO, XIP, MTO, AIM, and ASY HeadlinesRecent News About These CompaniesMatador Resources Co (MTDR) Stock: More Robust Than the Numbers Suggest?October 2, 2024 | bovnews.comBMiningNewsBreaks – Torr Metals Inc. (TSX.V: TMET) Positioned for Opportunities Presented by Canada’s Abundant ResourcesSeptember 25, 2024 | msn.comMiningNewsBreaks – Torr Metals Inc. (TSX.V: TMET) Announces $600K Non-Brokered Private PlacementSeptember 18, 2024 | msn.comMiningNewsBreaks – Torr Metals Inc. (TSX.V: TMET) Tapping ‘Tremendous Opportunity’ at Filion Gold ProjectAugust 23, 2024 | msn.comInvestorNewsBreaks – Torr Metals Inc. (TSXV: TMET) Appoints Global Mining Sector Veteran to the Board of DirectorsAugust 14, 2024 | msn.comFEERF Freeport Resources Inc.April 26, 2024 | seekingalpha.comPJX Resources Inc. (PJX.V)April 24, 2024 | ca.finance.yahoo.comRGCO RGC Resources, Inc.April 10, 2024 | seekingalpha.comTaranis Resources Inc. (TRO.V)April 4, 2024 | ca.finance.yahoo.comWilton Resources Inc. (WIL.V)March 13, 2024 | ca.finance.yahoo.comCoinbase, Inc. v. SuskiFebruary 29, 2024 | scotusblog.comSVisa Inc. (V)February 22, 2024 | uk.finance.yahoo.comMason Resources Inc. (MGPHF)February 1, 2024 | ca.finance.yahoo.comEOG Resources IncFebruary 1, 2024 | morningstar.comMPegasus Resources Inc. (PEGA.V)November 4, 2023 | ca.finance.yahoo.comExGen Resources Inc. DOK Project: Mineralization Encountered in First 3 HolesSeptember 29, 2023 | markets.businessinsider.comLabrador Resources Inc. (LTX.V)September 13, 2023 | ca.finance.yahoo.comCRI.V - Churchill Resources Inc.July 21, 2023 | ca.finance.yahoo.comRBX.V - Robex Resources Inc.May 31, 2023 | ca.finance.yahoo.comNorthern Superior Resources Inc. (SUP.V)April 13, 2023 | ca.finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 2025Is It Too Late to Jump on the Nuclear Bandwagon? By Jordan Chussler | August 25, 2025AI Glasses to Replace Smartphones? Meta Is Taking Aim at AppleBy Leo Miller | August 16, 2025Advanced Micro Devices' 2026 Forecasts Are Way Too LowBy Thomas Hughes | September 5, 2025Beyond DIY: Home Depot's Conquest of the Professional MarketBy Jeffrey Neal Johnson | September 10, 2025RCDO, XIP, MTO, AIM, and ASY Company DescriptionsAIM ImmunoTech NYSE:AIM$2.60 0.00 (0.00%) Closing price 09/12/2025 03:59 PM EasternExtended Trading$2.59 -0.01 (-0.38%) As of 09/12/2025 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's lead product candidate is Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat human papilloma viruses, and genital warts, a sexually transmitted disease. AIM ImmunoTech Inc. has agreements with Amarex Clinical Research LLC; University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente; Jubilant HollisterStier; Sterling Pharma Solutions; Erasmus University Medical Center Rotterdam; Azenova, LLC; and Alcami Corporation. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.Metanor Resources Inc. (MTO.V) CVE:MTOC$0.58 0.00 (0.00%) As of 09/25/2018Metanor Resources Inc. produces and sells gold in Canada. It also explores for and develops mining properties. The company primarily holds interests in the Bachelor mine and the Barry project, as well as approximately 15,000 hectares of exploration properties located in the mining-friendly jurisdiction of Québec. Metanor Resources Inc. was incorporated in 2003 and is headquartered in Val-d'Or, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/08 - 09/12 Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Football Season Is Here and DraftKings Stock Is Surging RH Stock Slides After Mixed Earnings and Tariff Concerns Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
